Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dual versus concomitant quadruple therapy for chronic Helicobacter pylori infection
PACTR202503761708458Completed
- Sponsor
- Individual
- Start
- Jan 2018
- Countries
- 1
01
Overview
Trial in Helicobacter pylori infection, sponsored by Individual. Primary endpoint: Helicobacter pylori eradication rate in intention-to-treat population. Started Jan 2018; status: completed.
02
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on PACTR202503761708458.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202503761708458.